Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Causal information changes how we reason: a mixed-methods analysis of decision-making with causal information.

Frontiers in cognition·2026
Same author

Cognitive processes and neurophysiological mechanisms of time processing in Parkinson's disease: A narrative review.

Neuroscience and biobehavioral reviews·2026
Same author

Evaluation of the effects of DBS in the caudal Zona incerta on brain activity during a working memory task in patients with essential tremor.

Neuroimage. Reports·2025
Same author

Subjective Well-Being and Its Predictors in Parkinson's Disease and Dystonia: A Comparative Study.

Movement disorders clinical practice·2025
Same author

Predictors of Loneliness in Parkinson's Disease and Craniocervical Dystonia.

Movement disorders clinical practice·2025
Same author

Less is more: Local focus in continuous time causal learning.

Journal of experimental psychology. Learning, memory, and cognition·2025
Same journal

Prevalence and modulation of rat off-track head scanning on linear tracks: possible implications for representational and dynamic properties of hippocampal place cells.

Neuropsychologia·2026
Same journal

Identifying networks within an fMRI multivariate searchlight analysis.

Neuropsychologia·2026
Same journal

Modulating sentence comprehension in people with aphasia through anodal tDCS: A double-blind randomized cross-over study.

Neuropsychologia·2026
Same journal

Deficient processing of regularity violations during visuospatial neglect: a visual mismatch negativity study.

Neuropsychologia·2026
Same journal

Seeing is believing: mental imagery amplifies moral, emotional, and motivational responding to mentally constructed hypothetical events.

Neuropsychologia·2026
Same journal

From past recall to future projection: What does verb tense production reveal about mental time travel in Alzheimer's disease?

Neuropsychologia·2026
See all related articles

Related Experiment Video

Updated: Jun 17, 2026

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
10:32

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease

Published on: June 17, 2013

Medication impairs probabilistic classification learning in Parkinson's disease.

Marjan Jahanshahi1, Leonora Wilkinson, Harpreet Gahir

  • 1Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, Queen Square, London, WC1N 3 BG, United Kingdom. m.jahanshahi@ion.ucl.ac.uk

Neuropsychologia
|December 17, 2009
PubMed
Summary
This summary is machine-generated.

Levodopa medication improves Parkinson's disease motor symptoms but impairs cognitive learning. Reducing medication levels may help preserve learning abilities in Parkinson's patients.

Related Experiment Videos

Last Updated: Jun 17, 2026

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
10:32

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease

Published on: June 17, 2013

Area of Science:

  • Neuroscience
  • Cognitive Science
  • Pharmacology

Background:

  • Parkinson's disease (PD) involves dopamine deficiency, impacting motor and cognitive functions.
  • Levodopa is a primary treatment for PD motor symptoms, but its cognitive effects are debated.
  • Dopamine plays a crucial role in both motor control and learning processes.

Purpose of the Study:

  • To investigate the impact of levodopa medication on probabilistic classification learning in Parkinson's disease patients.
  • To test the hypothesis that levodopa-induced tonic dopamine increase disrupts learning by overshadowing essential phasic dopamine release.

Main Methods:

  • 11 Parkinson's disease patients and 13 healthy controls completed the weather prediction task (WPT).
  • PD patients were tested both on and off their usual levodopa medication.
  • The WPT assesses probabilistic classification learning over 200 trials.

Main Results:

  • PD patients on levodopa performed significantly worse on the WPT compared to controls.
  • When PD patients were off medication, their WPT performance was equivalent to controls.
  • Performance on the WPT was significantly better in PD patients off medication compared to when they were on medication.

Conclusions:

  • Levodopa medication significantly impairs cognitive learning in Parkinson's disease patients.
  • The findings support the hypothesis that elevated tonic dopamine levels mask crucial phasic dopamine signals needed for learning.
  • Careful titration of levodopa is recommended to balance motor symptom improvement with cognitive function preservation.